Verve Therapeutics Inc (VERV) stock is lower by -51.23% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives VERV stock a score of 33 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 2. VERV's rank also includes a long-term technical score of 4. VERV has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VERV!